{"id":145171,"date":"2023-05-05T10:49:01","date_gmt":"2023-05-05T14:49:01","guid":{"rendered":"https:\/\/44.250.171.167\/?p=145171"},"modified":"2023-05-05T10:49:03","modified_gmt":"2023-05-05T14:49:03","slug":"earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-3-yoy","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-3-yoy\/","title":{"rendered":"Earnings | ALEMBIC PHARMACEUTICALS LIMITED (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1.3% YoY."},"content":{"rendered":"\n<p>Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients. Founded in 1907, the company has a strong focus on research and development, and has invested heavily in state-of-the-art facilities and advanced technologies to deliver high-quality products. Alembic Pharmaceuticals has a wide range of therapeutic products, including medicines for cardiovascular, anti-infective, gastroenterology, and central nervous system disorders, among others.<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>ALEMBIC PHARMACEUTICALS LIMITED reported Total Income for Q4 FY23 of \u20b91,407 Crore down from \u20b91,426 Crore year on year, a negative growth of 1.3%.<\/li><li>Total Expenses for Q4 FY23 of \u20b91,288 Crore down from \u20b91,385 Crore year on year, a negative growth of 7%.<\/li><li>Consolidated Net Profit of \u20b9152 Crore, up 590% from \u20b922 Crore in the same quarter of the previous year.\u00a0<\/li><li>The Earnings per Share is \u20b97.76, up 599% from \u20b91.11 in the same quarter of the previous year.<\/li><\/ul>\n\n\n\n<figure class=\"wp-block-image size-large\"><img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"527\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-1024x527.png\" alt=\"\" class=\"wp-image-145172\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-1024x527.png 1024w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-300x154.png 300w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-768x395.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-1536x790.png 1536w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-22-2048x1053.png 2048w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>Alembic Pharmaceuticals is an Indian pharmaceutical company that specializes in the development, manufacturing, and marketing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients. Founded in 1907, the company has a strong focus on research and development, and has invested heavily in state-of-the-art facilities and advanced technologies to deliver high-quality products. [&hellip;]<\/p>\n","protected":false},"author":1932,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[392],"tags":[1115],"class_list":["post-145171","post","type-post","status-publish","format-standard","hentry","category-earnings","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":147370,"url":"https:\/\/alphastreet.com\/india\/earnings-alembic-pharmaceuticals-limited-nse-aplltd-q4fy23-results-out-total-income-fell-1-yoy\/","url_meta":{"origin":145171,"position":0},"title":"Earnings | Alembic Pharmaceuticals Limited (NSE: APLLTD): Q4FY23 Results Out; Total Income fell 1% YoY.","author":"Divyansh_Kasana","date":"May 26, 2023","format":false,"excerpt":"Alembic Pharmaceuticals is a leading player in the pharmaceutical industry, specializing in the development, manufacturing, and marketing of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). The company boasts three research and development (R&D) facilities dedicated to innovative drug development and technological advancements. With a strong focus on quality\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/05\/4b0b185d-fd09-4e7e-947d-ef141089055f-1-8.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":141223,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-nse-aplltd-q3-fy23-results-out-total-income-rises-18-yoy\/","url_meta":{"origin":145171,"position":1},"title":"Alembic Pharmaceuticals LTD. (NSE: APLLTD): Q3 FY23 Results Out; Total Income Rises 18% YoY","author":"Divyansh_Kasana","date":"February 13, 2023","format":false,"excerpt":"Alembic Pharmaceuticals Ltd. (NSE:APLLTD) is an Indian pharmaceutical company that was founded in 1907. It is headquartered in Vadodara, Gujarat, and operates globally. The company specializes in the manufacturing of a wide range of pharmaceutical products, including active pharmaceutical ingredients, formulations, and nutraceuticals. Alembic Pharmaceuticals is known for its high-quality\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"","width":0,"height":0},"classes":[]},{"id":165765,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q2fy25-12-rise-in-profits\/","url_meta":{"origin":145171,"position":2},"title":"Alembic Pharmaceuticals Ltd Q2FY25; 12% rise in Profits","author":"Divyansh_Kasana","date":"November 21, 2024","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q2FY25 of \u20b91,648.00 Crores up from \u20b91,595.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/11\/BG.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":168418,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q4fy25-12-fall-in-profits\/","url_meta":{"origin":145171,"position":3},"title":"Alembic Pharmaceuticals Ltd Q4FY25; 12% fall in Profits","author":"Divyansh_Kasana","date":"May 19, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q4FY25 of \u20b91,770.00 Crores up from \u20b91,517.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/05\/I-10.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":167021,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-ltd-q3fy25-23-fall-in-profits\/","url_meta":{"origin":145171,"position":4},"title":"Alembic Pharmaceuticals Ltd Q3FY25; 23% fall in Profits","author":"Divyansh_Kasana","date":"February 21, 2025","format":false,"excerpt":"Alembic Pharmaceuticals is in the business of development, manufacturing, and marketing of Pharmaceuticals products i.e. Formulations and Active Pharmaceutical Ingredients. The company has 3 R&D and 5 manufacturing facilities. Financial Results: Alembic Pharmaceuticals Ltd reported Revenues for Q3FY25 of \u20b91,693.00 Crores up from \u20b91,631.00 Crore year on year, a rise\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/02\/B-9.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":169930,"url":"https:\/\/alphastreet.com\/india\/alembic-pharmaceuticals-q1-fy26-earnings-results-revenue-up-10-net-profit-rises-14-yoy\/","url_meta":{"origin":145171,"position":5},"title":"Alembic Pharmaceuticals Q1 FY26 Earnings Results","author":"Divyansh_Kasana","date":"August 8, 2025","format":false,"excerpt":"Alembic Pharmaceuticals Limited is a leading player in the pharmaceutical industry, engaged in the development, manufacturing, and marketing of formulations and active pharmaceutical ingredients (APIs). The company operates 3 R&D centers and 5 advanced manufacturing facilities, supporting global exports and a robust domestic presence. Presenting below are its Q1 FY26\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"APLLTD Q1 FY26 Earnings Results","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2025\/08\/APL.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145171","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1932"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=145171"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/145171\/revisions"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=145171"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=145171"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=145171"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}